SLB vs ZYME · P/E 12, rev $35.71B vs rev $76.3M
Schlumberger NV (SLB) versus Zymeworks Inc. Common Stock (ZYME) — a side-by-side from cached financials, not a winner call.
Schlumberger NV (SLB) is a oil & gas equipment & services company listed on US.
Zymeworks Inc. Common Stock (ZYME) is a biotechnology company listed on NASDAQ.
Latest reported SLB revenue for 2025-12-31 was $35.71B. Net income was $3.37B. Revenue was down 1.6% from 2024-12-31 to 2025-12-31. SLB currently screens at market cap $48.16B and trailing P/E 12.1.
Latest reported ZYME revenue for 2024-12-31 was $76.3M. Net income was -$122.7M. Revenue was up 0.4% from 2023-12-31 to 2024-12-31. ZYME currently screens at market cap $1.68B.
SLB currently screens at market cap $48.16B and trailing P/E 12.1. ZYME currently screens at market cap $1.68B.
Not investment advice. Open the SLB and ZYME stock pages for the full models.
Not investment advice.